Biome Biologicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-10-2024
- Paid Up Capital ₹ 1.00 M
as on 25-10-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.12 M
as on 25-10-2024
- Revenue 4906.82%
(FY 2023)
- Profit 1321.67%
(FY 2023)
- Ebitda 1794.73%
(FY 2023)
- Net Worth 1680.15%
(FY 2023)
- Total Assets 485.13%
(FY 2023)
About Biome Biologicals
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.12 M.
Sreemannarayana Pasumarthi, Pavan Velpuri, and Nithyagovind serve as directors at the Company.
- CIN/LLPIN
U24299TG2021PTC147890
- Company No.
147890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biome Biologicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreemannarayana Pasumarthi  | Director | 20-Jan-2021 | Current |
| Pavan Velpuri | Director | 20-Jan-2021 | Current |
| Nithyagovind | Nominee Director | 07-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Biome Biologicals.
Biome Biologicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4906.82% increase. The company also saw a substantial improvement in profitability, with a 1321.67% increase in profit. The company's net worth Soared by an impressive increase of 1680.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biome Biologicals?
In 2023, Biome Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kph Infotech Private LimitedActive 4 years 3 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
Exome Life Sciences Private LimitedActive 7 years 8 monthsSreemannarayana Pasumarthi and Pavan Velpuri are mutual person
Intron Life Sciences Private LimitedActive 6 years 2 monthsSreemannarayana Pasumarthi, Pavan Velpuri and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Mar 2024 | ₹2.12 M | Open |
How Many Employees Work at Biome Biologicals?
Biome Biologicals has a workforce of 13 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biome Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biome Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
